| Literature DB >> 20978356 |
Abstract
MicroRNAs (miRNAs) are potent regulators of mRNA stability and thereby protein expression. As such, miRNAs have become of interest as possible therapeutics and/or therapeutic targets. In this context, small complementary miRNA sequences known as antagomirs could be used to inhibit miRNA activity, while miRNA mimics could confer gain-of-function activity. However, a note of caution is sounded by Patrick et al. in this issue of the JCI, as they show that although recent reports have suggested that an miR-21 antagomir might be therapeutically useful in preventing heart failure in mice, genetic deletion of miR-21 does not confer a similar phenotype, suggesting possible confounding factors that are only now beginning to be revealed in the techniques used to study miRNA biology.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20978356 PMCID: PMC2964999 DOI: 10.1172/JCI44596
Source DB: PubMed Journal: J Clin Invest ISSN: 0021-9738 Impact factor: 14.808